Evidence map›Paper›PMID 19167484›Full record

ArticleCellular signalling2009

Enhanced clonogenic survival induced by protein tyrosine phosphatase (PTP) inhibition after Cr(VI) exposure is mediated by c-Raf and Ras activity.

Dongsoon Bae, Tura C Camilli, Ngoc-Tram Ha, Susan Ceryak

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Chromium genotoxicity: A double-edged sword.Chemico-biological interactions · 2010
    Review
  2. C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
  3. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing.Biochemical and biophysical research communications · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dongsoon BaeDepartment of Pharmacology and Physiology, The George Washington University Medical Center, Washington, DC 20037, United States.
Tura C Camilli
Ngoc-Tram Ha
Susan Ceryak
Washington University in St. Louis · US

Funding

Survival Signaling After Genotoxic InsultR01CA107972 · NCI · GEORGE WASHINGTON UNIVERSITY · PI CERYAK, SUSAN M · 2005 to 2009
$1.4M
NCI NIH HHS CA 107972NCI NIH HHS R01 CA107972
6 · The paper itself

Abstract

Our recent studies showed that maintenance of protein tyrosine phosphorylation by PTP inhibition enhanced cell growth, clonogenic survival, and mutagenesis after a single low-level Cr(VI) exposure, thereby suggesting that tyrosine phosphorylation-dependent signaling may govern inappropriate survival in human lung fibroblasts (HLFs). Our goal is to identify specific phospho-tyrosine regulator(s)/ downstream effectors involved in enhanced survival after Cr(VI) exposure and PTP inhibition. Phosphotyrosine profiling array showed that PTP inhibition following Cr(VI) exposure increased tyrosine phosphorylation of specific proteins, such as FGR and ABL, which are upstream regulators of both Erk and Akt pathways. To explore the roles of these pathways in the PTP-induced increase in clonogenic survival after Cr(VI) exposure, we examined the effect of combined Akt1 and Erk1/2 knockdown via siRNA technology. Akt1 and/or Erk1/2 silencing had no effect on the PTP inhibitor-induced increase in survival following Cr(VI) exposure, suggesting the presence of non-Akt/non-Erk-mediated survival signaling. Interestingly, geldanamycin, an HSP90 inhibitor and non-specific Raf inhibitor, abrogated the PTP inhibitor-mediated increase in survival following Cr(VI) exposure and abolished the expression/activity of c-Raf and activity of Mek. These findings prompted us to explore upstream regulators of Erk, i.e., Ras, c-Raf and Mek for their potential roles in clonogenic survival. GW5074, a specific c-Raf kinase inhibitor did not alter the effect of the PTP inhibitor but decreased Cr(VI)-mediated clonogenic lethality, potentially though Mek hyperactivation. A genetic approach with a c/a Mek1 mutant also showed that Mek activity was not directly associated with the PTP inhibitor effect. Finally, a genetic approach with d/n or c/a Ras and c-Raf mutants, showed that Ras and c-Raf activities play a substantive role in enhancing clonogenic survival by PTP inhibition following Cr(VI) insult. In conclusion, these studies highlight a novel pro-survival mechanism for clonogenic survival in the face of genotoxic stress in the presence of PTP inhibition via an Erk/Mek-independent and Ras/c-Raf-dependent regulation in normal human lung fibroblasts.

Indexed as

BenzoquinonesCell LineCell SurvivalChromiumDown-RegulationExtracellular Signal-Regulated MAP KinasesGene Knockdown TechniquesHumansIndolesLactams, MacrocyclicMAP Kinase Kinase KinasesPhenolsProtein Tyrosine PhosphatasesProto-Oncogene Proteins c-rafras ProteinsRNA, Small Interfering5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinoneBenzoquinonesChromiumExtracellular Signal-Regulated MAP KinasesgeldanamycinIndolesLactams, MacrocyclicMAP Kinase Kinase KinasesPhenolsProtein Tyrosine PhosphatasesProto-Oncogene Proteins c-rafras ProteinsRNA, Small Interfering

Identifiers

PMID19167484
PMCPMC2673100
OpenAlexW1990357629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.